A Phase I Trial of WEE1 Inhibition With Chemotherapy and Radiotherapy as Adjuvant Treatment, and a Window of Opportunity Trial With Cisplatin in Patients With Head and Neck Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2018
At a glance
- Drugs Adavosertib (Primary) ; Cisplatin (Primary)
- Indications Squamous cell cancer
- Focus Adverse reactions
- Acronyms WISTERIA
- 23 Jun 2017 Status changed from not yet recruiting to recruiting.
- 07 Jun 2017 Status changed from recruiting to not yet recruiting
- 04 May 2017 Planned initiation date changed from 1 Feb 2017 to 1 May 2017.